中南大学学报(医学版)
中南大學學報(醫學版)
중남대학학보(의학판)
JOURNAL OF CENTRAL SOUTH UNIVERSITY (MEDICAL SCIENCES)
2010年
6期
543-548
,共6页
何艳%蒋永芳%王谷丰%罗红雨%肖新强%邓春明%罗开忠%苏先狮
何豔%蔣永芳%王穀豐%囉紅雨%肖新彊%鄧春明%囉開忠%囌先獅
하염%장영방%왕곡봉%라홍우%초신강%산춘명%라개충%소선사
小干扰 RNA%HBV%HBV 核心抗原%磁性纳米
小榦擾 RNA%HBV%HBV 覈心抗原%磁性納米
소간우 RNA%HBV%HBV 핵심항원%자성납미
siRNA%HBV%HBV core gene%magnetic nanoparticles
目的:通过RNA干扰和纳米技术抑制HBV-DNA在体外的复制和HBV核心抗原的表达.方法:制备靶向HBV核心抗原(HBcAg)的纳米小干扰RNA(siRNA),利用U6启动子质粒转染入HepG2 2.2.15细胞;RT-PCR和Western印迹检测转染细胞HBV核心抗原在mRNA和蛋白水平的表达情况;real-time PCR 检测上清液HBV-DNA,放射免疫法检测细胞HBV表面抗原(HBsAg)、e抗原(HBeAg)、核心抗原(HBcAg).结果:成功构建了含磁性纳米的siRNA质粒;多种方法检测均显示转染后的细胞HBV核心抗原表达明显下降;其表面抗原、e抗原和HBV-DNA值均较对照组降低.结论:RNA干扰联合纳米技术可明显下调HBV核心抗原的表达,抑制HBV-DNA复制.
目的:通過RNA榦擾和納米技術抑製HBV-DNA在體外的複製和HBV覈心抗原的錶達.方法:製備靶嚮HBV覈心抗原(HBcAg)的納米小榦擾RNA(siRNA),利用U6啟動子質粒轉染入HepG2 2.2.15細胞;RT-PCR和Western印跡檢測轉染細胞HBV覈心抗原在mRNA和蛋白水平的錶達情況;real-time PCR 檢測上清液HBV-DNA,放射免疫法檢測細胞HBV錶麵抗原(HBsAg)、e抗原(HBeAg)、覈心抗原(HBcAg).結果:成功構建瞭含磁性納米的siRNA質粒;多種方法檢測均顯示轉染後的細胞HBV覈心抗原錶達明顯下降;其錶麵抗原、e抗原和HBV-DNA值均較對照組降低.結論:RNA榦擾聯閤納米技術可明顯下調HBV覈心抗原的錶達,抑製HBV-DNA複製.
목적:통과RNA간우화납미기술억제HBV-DNA재체외적복제화HBV핵심항원적표체.방법:제비파향HBV핵심항원(HBcAg)적납미소간우RNA(siRNA),이용U6계동자질립전염입HepG2 2.2.15세포;RT-PCR화Western인적검측전염세포HBV핵심항원재mRNA화단백수평적표체정황;real-time PCR 검측상청액HBV-DNA,방사면역법검측세포HBV표면항원(HBsAg)、e항원(HBeAg)、핵심항원(HBcAg).결과:성공구건료함자성납미적siRNA질립;다충방법검측균현시전염후적세포HBV핵심항원표체명현하강;기표면항원、e항원화HBV-DNA치균교대조조강저.결론:RNA간우연합납미기술가명현하조HBV핵심항원적표체,억제HBV-DNA복제.
Objective To investigate the inhibitory effect of downregulation of hepatitis B virus (HBV) core gene (HBcAg) expression by RNA interference and magnetic nanoparticles on both HBV DNA replication and expression in vitro. Methods HepG2 2.2.15 cells were transfected with U6 promoter plasmids coding for small interfering RNA (siRNA) targeting HBV core gene using magnetic nanoparticles. RT-PCR and Western blot were used to assess the mRNA and protein expression HBV core antigen. Real-time PCR was used to evaluate the suppression efficiency of HBV-DNA replication and expression; and radioimmunoassay was used for HBV surface antigen (HBsAg), core antigen (HBcAg), and e antigen (HBeAg) detection. Results We successfully constructed nanoparticles with siRNA plasmid targeting HBV core antigen; HBcAg mRNA and HBV core antigen protein levels were significantly reduced in the transfected cells. HBV-DNA downregulation was estimated at 4-5 logs and the HBsAg and HBeAg levels were also reduced compared with the controls. Conclusion Downregulation of HBV core gene using RNAi technology and magnetic nanoparticles can potentially be used as a therapeutic strategy for Hepatitis B.